1. A6.35 Differential B and plasma cell homing mechanisms in inflamed kidneys of NZB/W F1 mice. (13th February 2015) Authors: Hoyer, BF; Cheng, Q; Taddeo, A; Khodadadi, L; Wu, K; Rudolph, B; Radbruch, A; Manz, RF; Hiepe, F Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A8.26 Bortezomib ameliorates the disease progression due to ovalbumin immunisation in NZB/W F1 lupus prone mice. (13th February 2015) Authors: Khodadadi, L; Cheng, Q; Winter, O; Taddeo, A; Radbruch, A; Hoyer, BF; Hiepe, F Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A8.28 Depletion of autoantibody-secreting plasma cells based on the specificity of the secreted antibody. (13th February 2015) Authors: Taddeo, A; Hoyer, BF; Gerl, V; Chang, HD; Pelz, A; Kohler, S; Radbruch, A; Hiepe, F Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Disturbances of B cell homeostasis in takayasu arteritis and giant cell arteritis. (22nd February 2012) Authors: Hoyer, B F; Mei, H; Taddeo, A; Biesen, R; Burmester, G-R; Radbruch, A; Hiepe, F Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 1 Page Start: A42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Refractory SLE patients respond to the proteasome inhibitor bortezomib. (22nd February 2012) Authors: Hiepe, F; Alexander, T; Peukert, R; Rubbert, A; Rech, J; Braun, T; Schott, G; Wiesener, M; Eckardt, K U; Baeuerle, M; Reisch, A; Hoyer, B; Taddeo, A; Burmester, G; Schett, G; Radbruch, A; Voll, R E Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 1 Page Start: A15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. S1D:6 Targeting plasma cells and their precursors by immunoablation versus bortezomib plus rituximab in systemic lupus erythemtosus. (21st March 2018) Authors: Alexander, T; Hoyer, B; Cheng, Q; Khodadadi, L; Taddeo, A; Klotsche, J; Thiel, A; Burmester, G; Radbruch, A; Arnold, R; Hiepe, F Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 1 Page Start: A4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Targeting autoreactive plasma cells in autoimmunity: a new treatment approach combining plasma cell and B cell depletion. (22nd February 2012) Authors: Taddeo, A; Hoyer, B F; Chang, H-D; Radbruch, A; Hiepe, F Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 1 Page Start: A2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗